Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Theratechnologies (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company, has scheduled its fourth quarter and full year fiscal 2024 financial results announcement and business update for February 26, 2025, at 8:30 a.m. ET.
The conference call will be led by Paul Lévesque, President and CEO, alongside other key management team members including Philippe Dubuc (CFO), Christian Marsolais (CMO), and John Leasure (Global Commercial Officer). The team will present prepared remarks followed by a Q&A session.
Participants are advised to join the call ten minutes before start time. The presentation will be accessible via webcast and telephone conference, with replay options available until March 5, 2025.
Theratechnologies (TSX: TH) (NASDAQ: THTX), un'azienda biopharmaceutica specializzata, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno fiscale 2024, insieme a un aggiornamento aziendale, per il 26 febbraio 2025, alle 8:30 ET.
La conferenza telefonica sarà guidata da Paul Lévesque, Presidente e CEO, insieme ad altri membri chiave del team di gestione, tra cui Philippe Dubuc (CFO), Christian Marsolais (CMO) e John Leasure (Global Commercial Officer). Il team presenterà osservazioni preparate seguite da una sessione di domande e risposte.
Si consiglia ai partecipanti di unirsi alla chiamata dieci minuti prima dell'orario di inizio. La presentazione sarà accessibile tramite webcast e conferenza telefonica, con opzioni di riproduzione disponibili fino al 5 marzo 2025.
Theratechnologies (TSX: TH) (NASDAQ: THTX), una empresa biofarmacéutica especializada, ha programado el anuncio de resultados financieros del cuarto trimestre y del año fiscal completo 2024, junto con una actualización empresarial, para el 26 de febrero de 2025, a las 8:30 a.m. ET.
La llamada de conferencia será liderada por Paul Lévesque, Presidente y CEO, junto a otros miembros clave del equipo directivo, incluyendo a Philippe Dubuc (CFO), Christian Marsolais (CMO) y John Leasure (Director Comercial Global). El equipo presentará comentarios preparados seguidos de una sesión de preguntas y respuestas.
Se aconseja a los participantes unirse a la llamada diez minutos antes de la hora de inicio. La presentación estará accesible a través de webcast y conferencia telefónica, con opciones de repetición disponibles hasta el 5 de marzo de 2025.
Theratechnologies (TSX: TH) (NASDAQ: THTX), 특수 생명공학 회사는 2025년 2월 26일 오전 8시 30분 ET에 2024 회계연도 4분기 및 전체 연도 재무 결과 발표와 비즈니스 업데이트를 예정하고 있습니다.
컨퍼런스 콜은 Paul Lévesque 회장 겸 CEO가 주도하며, Philippe Dubuc (CFO), Christian Marsolais (CMO), John Leasure (글로벌 상업 책임자)와 같은 다른 주요 경영진들이 함께합니다. 팀은 준비된 발언을 하고 질의응답 세션이 이어질 것입니다.
참가자는 시작 10분 전에 전화에 접속할 것을 권장합니다. 프레젠테이션은 웹캐스트와 전화 회의를 통해 접근 가능하며, 2025년 3월 5일까지 재생 옵션이 제공됩니다.
Theratechnologies (TSX: TH) (NASDAQ: THTX), une entreprise biopharmaceutique spécialisée, a programmé l'annonce des résultats financiers du quatrième trimestre et de l'année fiscale complète 2024, ainsi qu'une mise à jour commerciale, pour le 26 février 2025 à 8h30 HE.
La conférence téléphonique sera dirigée par Paul Lévesque, Président et CEO, accompagné d'autres membres clés de l'équipe de direction, dont Philippe Dubuc (CFO), Christian Marsolais (CMO) et John Leasure (Directeur Commercial Global). L'équipe présentera des remarques préparées suivies d'une session de questions-réponses.
Il est conseillé aux participants de rejoindre l'appel dix minutes avant l'heure de début. La présentation sera accessible par webdiffusion et conférence téléphonique, avec des options de rediffusion disponibles jusqu'au 5 mars 2025.
Theratechnologies (TSX: TH) (NASDAQ: THTX), ein spezialisiertes biopharmazeutisches Unternehmen, hat die Bekanntgabe der finanziellen Ergebnisse des vierten Quartals und des gesamten Geschäftsjahres 2024 sowie ein Unternehmensupdate für den 26. Februar 2025 um 8:30 Uhr ET angesetzt.
Die Telefonkonferenz wird von Paul Lévesque, Präsident und CEO, geleitet, zusammen mit anderen wichtigen Mitgliedern des Managementteams, darunter Philippe Dubuc (CFO), Christian Marsolais (CMO) und John Leasure (Global Commercial Officer). Das Team wird vorbereitete Bemerkungen präsentieren, gefolgt von einer Frage- und Antwortsitzung.
Teilnehmer werden gebeten, zehn Minuten vor Beginn der Sitzung einzutreten. Die Präsentation wird über Webcast und Telefonkonferenz zugänglich sein, mit Rückspielmöglichkeiten bis zum 5. März 2025.
- None.
- None.
MONTREAL, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care, today announced the Company will report financial results and provide a business update for its fourth quarter and full year fiscal 2024 ended November 30 on Wednesday, February 26, 2025, at 8:30 a.m. ET.
The call will be hosted by Paul Lévesque, President and Chief Executive Officer, who will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer. They will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.
| CONFERENCE CALL INFORMATION | |
| Conference Call Date | February 26, 2025 |
| Conference Call Time | 8:30 a.m. ET |
| Webcast link | https://edge.media-server.com/mmc/p/2h9ningt |
| Dial in | 1-888-513-4119 (toll free) or 1-412-902-6615 (international) |
| Access Code | 4430181 |
| CONFERENCE CALL REPLAY | |
| Toll Free | 1-877-344-7529 (US) / 1-855-669-9658 (Canada) |
| International Toll | 1-412-317-0088 |
| Replay Access Code | 3856571 |
| Replay End Date | March 5, 2025 |
| To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html | |
An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X.
Contacts:
Investor inquiries:
Joanne Choi
Senior Director, Investor Relations
jchoi@theratech.com
1-551-261-0401
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) release its Q4 and FY 2024 earnings?
How can investors access THTX's Q4 2024 earnings call?
Who will be presenting at Theratechnologies' Q4 2024 earnings call?
Until when will THTX's Q4 2024 earnings call replay be available?
